Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alena Reguzova

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 26, 2022
Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell ResponsesMelanie Müller, Alena Reguzova, Markus W Löffler, et al.
Vaccines|January 28, 2026
Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based VaccinesAlena Reguzova, Melanie Müller, Madeleine Fandrich, et al.
Vaccines|June 14, 2020
<i>Orf Virus</i>-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived EpitopesAlena Reguzova, Michael Ghosh, Melanie Müller, et al.
Biomedicines|December 24, 2021
A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept StudyAlena Reguzova, Nico Fischer, Melanie Müller, et al.
Plos One|March 19, 2015
Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogensAlena Reguzova, Denis Antonets, Larisa Karpenko, et al.
Frontiers in Immunology|December 4, 2025
Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spikeAlena Reguzova, Verena Haug, Melanie Müller, et al.
Frontiers in Immunology|October 6, 2025
Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in miceAlena Reguzova, Verena Haug, Carina Metz, et al.
Viruses|February 2, 2019
Genomic Characterization of <i>Orf Virus</i> Strain D1701-V (<i>Parapoxvirus</i>) and Development of Novel Sites for Multiple Transgene ExpressionHanns-Joachim Rziha, Mathias Büttner, Melanie Müller, et al.
NPJ Vaccines|October 16, 2024
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2Alena Reguzova, Melanie Müller, Felix Pagallies, et al.
Vaccines|November 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine BoosterMeral Esen, Johanna Fischer-Herr, Julian Justin Gabor, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 26, 2022
Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell ResponsesMelanie Müller, Alena Reguzova, Markus W Löffler, et al.
Vaccines|January 28, 2026
Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based VaccinesAlena Reguzova, Melanie Müller, Madeleine Fandrich, et al.
Vaccines|June 14, 2020
<i>Orf Virus</i>-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived EpitopesAlena Reguzova, Michael Ghosh, Melanie Müller, et al.
Biomedicines|December 24, 2021
A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept StudyAlena Reguzova, Nico Fischer, Melanie Müller, et al.
Plos One|March 19, 2015
Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogensAlena Reguzova, Denis Antonets, Larisa Karpenko, et al.
Frontiers in Immunology|December 4, 2025
Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spikeAlena Reguzova, Verena Haug, Melanie Müller, et al.
Frontiers in Immunology|October 6, 2025
Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in miceAlena Reguzova, Verena Haug, Carina Metz, et al.
Viruses|February 2, 2019
Genomic Characterization of <i>Orf Virus</i> Strain D1701-V (<i>Parapoxvirus</i>) and Development of Novel Sites for Multiple Transgene ExpressionHanns-Joachim Rziha, Mathias Büttner, Melanie Müller, et al.
NPJ Vaccines|October 16, 2024
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2Alena Reguzova, Melanie Müller, Felix Pagallies, et al.
Vaccines|November 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine BoosterMeral Esen, Johanna Fischer-Herr, Julian Justin Gabor, et al.
Pageof 1